Mucosal adjuvanticity of immunostimulatory DNA sequences.
Horner
A A
AA
Department of Medicine, University of California, San Diego, La Jolla 92093-0663, USA.
Cinman
N
N
Ronaghy
A
A
Raz
E
E
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000941:Antigens / Q000276:immunology; D018899:CpG Islands / Q000276:immunology; D004247:DNA / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology; D004274:DNA, Recombinant / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology; D004333:Drug Administration Routes; D005753:Gastric Mucosa / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007115:Immunization Schedule; D007070:Immunoglobulin A / Q000096:biosynthesis / Q000276:immunology; D007371:Interferon-gamma / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism; D008211:Lymphocyte Cooperation / Q000187:drug effects; D051379:Mice; D009092:Mucous Membrane / Q000187:drug effects / Q000276:immunology*; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000276:immunology / Q000494:pharmacology; D009928:Organ Specificity; D013154:Spleen / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology; D001616:beta-Galactosidase / Q000276:immunology
D000276:Adjuvants, Immunologic; D000941:Antigens; D004274:DNA, Recombinant; D007070:Immunoglobulin A; D009838:Oligodeoxyribonucleotides; D016753:Interleukin-10; D007371:Interferon-gamma; D004247:DNA; D001616:beta-Galactosidase